HEADER HYDROLASE, TRANSFERASE 14-MAR-17 5V5I TITLE OTU PROTEASE OF CRIMEAN CONGO HEMORRHAGIC FEVER VIRUS BOUND TO TITLE 2 UBIQUITIN VARIANT CC.1 COMPND MOL_ID: 1; COMPND 2 MOLECULE: RNA-DIRECTED RNA POLYMERASE L; COMPND 3 CHAIN: A, C; COMPND 4 SYNONYM: PROTEIN L,LARGE STRUCTURAL PROTEIN,REPLICASE,TRANSCRIPTASE; COMPND 5 EC: 3.4.19.12,2.7.7.48; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: NOTE: THE ACTIVE SITE CYS IS OXIDIZED TO SULFENIC COMPND 8 ACID; COMPND 9 MOL_ID: 2; COMPND 10 MOLECULE: UBIQUITIN VARIANT CC.1; COMPND 11 CHAIN: B, D; COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS (STRAIN SOURCE 3 NIGERIA/IBAR10200/1970); SOURCE 4 ORGANISM_COMMON: CCHFV; SOURCE 5 ORGANISM_TAXID: 652961; SOURCE 6 STRAIN: NIGERIA/IBAR10200/1970; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: SYNTHETIC CONSTRUCT; SOURCE 11 ORGANISM_TAXID: 32630; SOURCE 12 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 13 EXPRESSION_SYSTEM_TAXID: 511693 KEYWDS OVARIAN TUMOR DOMAIN PROTEASE, DEUBIQUITINASE, UBIQUITIN VARIANT, KEYWDS 2 HYDROLASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR B.KHARE,B.L.MARK REVDAT 5 08-JAN-20 5V5I 1 REMARK REVDAT 4 21-FEB-18 5V5I 1 JRNL REVDAT 3 20-SEP-17 5V5I 1 REMARK REVDAT 2 07-JUN-17 5V5I 1 JRNL REVDAT 1 10-MAY-17 5V5I 0 JRNL AUTH W.ZHANG,B.A.BAILEY-ELKIN,R.C.M.KNAAP,B.KHARE,T.J.DALEBOUT, JRNL AUTH 2 G.G.JOHNSON,P.B.VAN KASTEREN,N.J.MCLEISH,J.GU,W.HE, JRNL AUTH 3 M.KIKKERT,B.L.MARK,S.S.SIDHU JRNL TITL OTU PROTEASE OF CRIMEAN CONGO HEMORRHAGIC FEVER VIRUS BOUND JRNL TITL 2 TO UBIQUITIN VARIANT CC.1 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (DEV_2328: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.17 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 26414 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.226 REMARK 3 R VALUE (WORKING SET) : 0.222 REMARK 3 FREE R VALUE : 0.273 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.570 REMARK 3 FREE R VALUE TEST SET COUNT : 2000 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 40.1737 - 5.3002 0.99 1895 155 0.1982 0.2293 REMARK 3 2 5.3002 - 4.2084 1.00 1791 147 0.1564 0.2118 REMARK 3 3 4.2084 - 3.6769 1.00 1766 145 0.1788 0.2153 REMARK 3 4 3.6769 - 3.3409 1.00 1757 144 0.2023 0.2310 REMARK 3 5 3.3409 - 3.1015 1.00 1745 143 0.2236 0.2974 REMARK 3 6 3.1015 - 2.9187 1.00 1758 144 0.2555 0.2963 REMARK 3 7 2.9187 - 2.7726 1.00 1731 142 0.2557 0.3337 REMARK 3 8 2.7726 - 2.6519 1.00 1716 140 0.2599 0.3223 REMARK 3 9 2.6519 - 2.5498 1.00 1744 143 0.2532 0.3048 REMARK 3 10 2.5498 - 2.4618 1.00 1724 141 0.2497 0.3213 REMARK 3 11 2.4618 - 2.3849 1.00 1710 141 0.2625 0.3332 REMARK 3 12 2.3849 - 2.3167 1.00 1713 139 0.2839 0.3316 REMARK 3 13 2.3167 - 2.2557 1.00 1710 140 0.3007 0.3532 REMARK 3 14 2.2557 - 2.2007 0.96 1654 136 0.3302 0.3956 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.300 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 30.560 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.002 3818 REMARK 3 ANGLE : 0.492 5170 REMARK 3 CHIRALITY : 0.042 581 REMARK 3 PLANARITY : 0.002 665 REMARK 3 DIHEDRAL : 13.354 2280 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5V5I COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-MAR-17. REMARK 100 THE DEPOSITION ID IS D_1000224060. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-OCT-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC VARIMAX HF REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV++ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26471 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 43.050 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 4.900 REMARK 200 R MERGE (I) : 0.10700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.27 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.3 REMARK 200 DATA REDUNDANCY IN SHELL : 4.50 REMARK 200 R MERGE FOR SHELL (I) : 0.61500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.93 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.98 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 30% (W/V) PEG6000, 1.0M LITHIUM REMARK 280 CHLORIDE AND 0.1M SODIUM ACETATE, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 2 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 X,-Y,-Z REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 -X,-Y+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 41.61100 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 75.44300 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 41.61100 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 75.44300 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1900 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10750 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1950 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 10950 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -4 REMARK 465 PRO A -3 REMARK 465 LEU A -2 REMARK 465 GLY A -1 REMARK 465 GLU A 162 REMARK 465 THR A 163 REMARK 465 ASP A 164 REMARK 465 THR A 165 REMARK 465 ARG A 166 REMARK 465 GLU A 167 REMARK 465 ALA A 168 REMARK 465 LEU A 169 REMARK 465 MET B -26 REMARK 465 ALA B -25 REMARK 465 HIS B -24 REMARK 465 HIS B -23 REMARK 465 HIS B -22 REMARK 465 HIS B -21 REMARK 465 HIS B -20 REMARK 465 HIS B -19 REMARK 465 VAL B -18 REMARK 465 THR B -17 REMARK 465 SER B -16 REMARK 465 LEU B -15 REMARK 465 TYR B -14 REMARK 465 LYS B -13 REMARK 465 LYS B -12 REMARK 465 ALA B -11 REMARK 465 GLY B -10 REMARK 465 SER B -9 REMARK 465 THR B -8 REMARK 465 ASP B -7 REMARK 465 TYR B -6 REMARK 465 LYS B -5 REMARK 465 ASP B -4 REMARK 465 ASP B -3 REMARK 465 ASP B -2 REMARK 465 ASP B -1 REMARK 465 LYS B 0 REMARK 465 GLY B 76 REMARK 465 ARG B 77 REMARK 465 ARG B 78 REMARK 465 GLY C -4 REMARK 465 PRO C -3 REMARK 465 LEU C -2 REMARK 465 GLY C -1 REMARK 465 SER C 0 REMARK 465 GLU C 162 REMARK 465 THR C 163 REMARK 465 ASP C 164 REMARK 465 THR C 165 REMARK 465 ARG C 166 REMARK 465 GLU C 167 REMARK 465 ALA C 168 REMARK 465 LEU C 169 REMARK 465 MET D -26 REMARK 465 ALA D -25 REMARK 465 HIS D -24 REMARK 465 HIS D -23 REMARK 465 HIS D -22 REMARK 465 HIS D -21 REMARK 465 HIS D -20 REMARK 465 HIS D -19 REMARK 465 VAL D -18 REMARK 465 THR D -17 REMARK 465 SER D -16 REMARK 465 LEU D -15 REMARK 465 TYR D -14 REMARK 465 LYS D -13 REMARK 465 LYS D -12 REMARK 465 ALA D -11 REMARK 465 GLY D -10 REMARK 465 SER D -9 REMARK 465 THR D -8 REMARK 465 ASP D -7 REMARK 465 TYR D -6 REMARK 465 LYS D -5 REMARK 465 ASP D -4 REMARK 465 ASP D -3 REMARK 465 ASP D -2 REMARK 465 ASP D -1 REMARK 465 LYS D 0 REMARK 465 GLY D 76 REMARK 465 ARG D 77 REMARK 465 ARG D 78 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ASP A 2 CG OD1 OD2 REMARK 470 ARG A 5 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 22 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 75 CG CD OE1 OE2 REMARK 470 GLU A 87 CG CD OE1 OE2 REMARK 470 LYS A 91 CE NZ REMARK 470 GLN A 149 CG CD OE1 NE2 REMARK 470 GLU B 16 CG CD OE1 OE2 REMARK 470 GLU B 24 CG CD OE1 OE2 REMARK 470 ASN B 25 CG OD1 ND2 REMARK 470 ARG B 54 NE CZ NH1 NH2 REMARK 470 GLN C 149 CG CD OE1 NE2 REMARK 470 GLU D 24 CD OE1 OE2 REMARK 470 LYS D 63 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 HD21 ASN C 20 O LEU D 8 1.59 REMARK 500 O GLU A 98 O HOH A 201 2.10 REMARK 500 OE2 GLU A 47 NH2 ARG A 156 2.11 REMARK 500 OD2 ASP C 55 O HOH C 201 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 123 -66.83 70.95 REMARK 500 ASP A 137 -169.93 -109.60 REMARK 500 GLN A 149 -77.14 -83.79 REMARK 500 ALA C 122 -155.18 -88.89 REMARK 500 SER C 124 -178.16 -64.52 REMARK 500 THR C 150 53.20 -143.84 REMARK 500 GLN C 160 4.95 -68.16 REMARK 500 ARG D 54 -178.60 -68.21 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5V5G RELATED DB: PDB REMARK 900 RELATED ID: 5V5H RELATED DB: PDB DBREF 5V5I A 1 169 UNP Q6TQR6 L_CCHFI 1 169 DBREF 5V5I B -26 78 PDB 5V5I 5V5I -26 78 DBREF 5V5I C 1 169 UNP Q6TQR6 L_CCHFI 1 169 DBREF 5V5I D -26 78 PDB 5V5I 5V5I -26 78 SEQADV 5V5I GLY A -4 UNP Q6TQR6 EXPRESSION TAG SEQADV 5V5I PRO A -3 UNP Q6TQR6 EXPRESSION TAG SEQADV 5V5I LEU A -2 UNP Q6TQR6 EXPRESSION TAG SEQADV 5V5I GLY A -1 UNP Q6TQR6 EXPRESSION TAG SEQADV 5V5I SER A 0 UNP Q6TQR6 EXPRESSION TAG SEQADV 5V5I GLY C -4 UNP Q6TQR6 EXPRESSION TAG SEQADV 5V5I PRO C -3 UNP Q6TQR6 EXPRESSION TAG SEQADV 5V5I LEU C -2 UNP Q6TQR6 EXPRESSION TAG SEQADV 5V5I GLY C -1 UNP Q6TQR6 EXPRESSION TAG SEQADV 5V5I SER C 0 UNP Q6TQR6 EXPRESSION TAG SEQRES 1 A 174 GLY PRO LEU GLY SER MET ASP PHE LEU ARG SER LEU ASP SEQRES 2 A 174 TRP THR GLN VAL ILE ALA GLY GLN TYR VAL SER ASN PRO SEQRES 3 A 174 ARG PHE ASN ILE SER ASP TYR PHE GLU ILE VAL ARG GLN SEQRES 4 A 174 PRO GLY ASP GLY ASN CSX PHE TYR HIS SER ILE ALA GLU SEQRES 5 A 174 LEU THR MET PRO ASN LYS THR ASP HIS SER TYR HIS TYR SEQRES 6 A 174 ILE LYS ARG LEU THR GLU SER ALA ALA ARG LYS TYR TYR SEQRES 7 A 174 GLN GLU GLU PRO GLU ALA ARG LEU VAL GLY LEU SER LEU SEQRES 8 A 174 GLU ASP TYR LEU LYS ARG MET LEU SER ASP ASN GLU TRP SEQRES 9 A 174 GLY SER THR LEU GLU ALA SER MET LEU ALA LYS GLU MET SEQRES 10 A 174 GLY ILE THR ILE ILE ILE TRP THR VAL ALA ALA SER ASP SEQRES 11 A 174 GLU VAL GLU ALA GLY ILE LYS PHE GLY ASP GLY ASP VAL SEQRES 12 A 174 PHE THR ALA VAL ASN LEU LEU HIS SER GLY GLN THR HIS SEQRES 13 A 174 PHE ASP ALA LEU ARG ILE LEU PRO GLN PHE GLU THR ASP SEQRES 14 A 174 THR ARG GLU ALA LEU SEQRES 1 B 105 MET ALA HIS HIS HIS HIS HIS HIS VAL THR SER LEU TYR SEQRES 2 B 105 LYS LYS ALA GLY SER THR ASP TYR LYS ASP ASP ASP ASP SEQRES 3 B 105 LYS MET GLN ILE PHE VAL LYS THR LEU LYS GLY HIS VAL SEQRES 4 B 105 ILE THR LEU GLU VAL GLU PRO SER ASP THR ILE GLU ASN SEQRES 5 B 105 VAL LYS ALA LYS ILE GLN ASP LYS GLU GLY ILE PRO PRO SEQRES 6 B 105 ASP GLN GLN ARG LEU ILE PHE ALA LEU GLN GLN LEU GLU SEQRES 7 B 105 ASP GLY ARG THR LEU SER ASP TYR ASN ILE GLN LYS GLU SEQRES 8 B 105 SER ASN LEU HIS LEU VAL LEU ARG LEU GLY GLY GLY ARG SEQRES 9 B 105 ARG SEQRES 1 C 174 GLY PRO LEU GLY SER MET ASP PHE LEU ARG SER LEU ASP SEQRES 2 C 174 TRP THR GLN VAL ILE ALA GLY GLN TYR VAL SER ASN PRO SEQRES 3 C 174 ARG PHE ASN ILE SER ASP TYR PHE GLU ILE VAL ARG GLN SEQRES 4 C 174 PRO GLY ASP GLY ASN CSX PHE TYR HIS SER ILE ALA GLU SEQRES 5 C 174 LEU THR MET PRO ASN LYS THR ASP HIS SER TYR HIS TYR SEQRES 6 C 174 ILE LYS ARG LEU THR GLU SER ALA ALA ARG LYS TYR TYR SEQRES 7 C 174 GLN GLU GLU PRO GLU ALA ARG LEU VAL GLY LEU SER LEU SEQRES 8 C 174 GLU ASP TYR LEU LYS ARG MET LEU SER ASP ASN GLU TRP SEQRES 9 C 174 GLY SER THR LEU GLU ALA SER MET LEU ALA LYS GLU MET SEQRES 10 C 174 GLY ILE THR ILE ILE ILE TRP THR VAL ALA ALA SER ASP SEQRES 11 C 174 GLU VAL GLU ALA GLY ILE LYS PHE GLY ASP GLY ASP VAL SEQRES 12 C 174 PHE THR ALA VAL ASN LEU LEU HIS SER GLY GLN THR HIS SEQRES 13 C 174 PHE ASP ALA LEU ARG ILE LEU PRO GLN PHE GLU THR ASP SEQRES 14 C 174 THR ARG GLU ALA LEU SEQRES 1 D 105 MET ALA HIS HIS HIS HIS HIS HIS VAL THR SER LEU TYR SEQRES 2 D 105 LYS LYS ALA GLY SER THR ASP TYR LYS ASP ASP ASP ASP SEQRES 3 D 105 LYS MET GLN ILE PHE VAL LYS THR LEU LYS GLY HIS VAL SEQRES 4 D 105 ILE THR LEU GLU VAL GLU PRO SER ASP THR ILE GLU ASN SEQRES 5 D 105 VAL LYS ALA LYS ILE GLN ASP LYS GLU GLY ILE PRO PRO SEQRES 6 D 105 ASP GLN GLN ARG LEU ILE PHE ALA LEU GLN GLN LEU GLU SEQRES 7 D 105 ASP GLY ARG THR LEU SER ASP TYR ASN ILE GLN LYS GLU SEQRES 8 D 105 SER ASN LEU HIS LEU VAL LEU ARG LEU GLY GLY GLY ARG SEQRES 9 D 105 ARG MODRES 5V5I CSX A 40 CYS MODIFIED RESIDUE MODRES 5V5I CSX C 40 CYS MODIFIED RESIDUE HET CSX A 40 12 HET CSX C 40 12 HETNAM CSX S-OXY CYSTEINE FORMUL 1 CSX 2(C3 H7 N O3 S) FORMUL 5 HOH *142(H2 O) HELIX 1 AA1 PHE A 3 LEU A 7 5 5 HELIX 2 AA2 ASN A 24 ASP A 27 5 4 HELIX 3 AA3 ASN A 39 MET A 50 1 12 HELIX 4 AA4 SER A 57 TYR A 73 1 17 HELIX 5 AA5 GLN A 74 VAL A 82 5 9 HELIX 6 AA6 SER A 85 SER A 95 1 11 HELIX 7 AA7 SER A 101 GLY A 113 1 13 HELIX 8 AA8 THR B 22 GLY B 35 1 14 HELIX 9 AA9 PRO B 37 ASP B 39 5 3 HELIX 10 AB1 PHE C 3 LEU C 7 5 5 HELIX 11 AB2 ASN C 24 TYR C 28 1 5 HELIX 12 AB3 ASN C 39 MET C 50 1 12 HELIX 13 AB4 SER C 57 TYR C 73 1 17 HELIX 14 AB5 GLN C 74 VAL C 82 5 9 HELIX 15 AB6 SER C 85 SER C 95 1 11 HELIX 16 AB7 SER C 101 MET C 112 1 12 HELIX 17 AB8 THR D 22 GLY D 35 1 14 HELIX 18 AB9 PRO D 37 ASP D 39 5 3 SHEET 1 AA1 7 THR A 10 ILE A 13 0 SHEET 2 AA1 7 GLN A 16 SER A 19 -1 O VAL A 18 N THR A 10 SHEET 3 AA1 7 VAL A 127 PHE A 133 -1 O LYS A 132 N TYR A 17 SHEET 4 AA1 7 ILE A 116 VAL A 121 -1 N ILE A 116 O PHE A 133 SHEET 5 AA1 7 VAL A 142 SER A 147 1 O LEU A 144 N ILE A 117 SHEET 6 AA1 7 HIS A 151 ILE A 157 -1 O ASP A 153 N LEU A 145 SHEET 7 AA1 7 PHE A 29 VAL A 32 -1 N VAL A 32 O ALA A 154 SHEET 1 AA2 5 VAL B 12 GLU B 16 0 SHEET 2 AA2 5 GLN B 2 LYS B 6 -1 N VAL B 5 O ILE B 13 SHEET 3 AA2 5 ASN B 66 LEU B 71 1 O LEU B 67 N PHE B 4 SHEET 4 AA2 5 GLN B 41 PHE B 45 -1 N ILE B 44 O HIS B 68 SHEET 5 AA2 5 GLN B 48 GLN B 49 -1 O GLN B 48 N PHE B 45 SHEET 1 AA3 7 THR C 10 ILE C 13 0 SHEET 2 AA3 7 GLN C 16 SER C 19 -1 O GLN C 16 N ILE C 13 SHEET 3 AA3 7 VAL C 127 PHE C 133 -1 O LYS C 132 N TYR C 17 SHEET 4 AA3 7 ILE C 116 VAL C 121 -1 N ILE C 116 O PHE C 133 SHEET 5 AA3 7 VAL C 142 SER C 147 1 O HIS C 146 N TRP C 119 SHEET 6 AA3 7 HIS C 151 ILE C 157 -1 O ASP C 153 N LEU C 145 SHEET 7 AA3 7 PHE C 29 VAL C 32 -1 N GLU C 30 O ARG C 156 SHEET 1 AA4 4 VAL D 12 GLU D 16 0 SHEET 2 AA4 4 GLN D 2 LYS D 6 -1 N ILE D 3 O LEU D 15 SHEET 3 AA4 4 ASN D 66 LEU D 71 1 O LEU D 67 N PHE D 4 SHEET 4 AA4 4 GLN D 41 ILE D 44 -1 N ILE D 44 O HIS D 68 LINK C ASN A 39 N CSX A 40 1555 1555 1.33 LINK C CSX A 40 N PHE A 41 1555 1555 1.33 LINK C ASN C 39 N CSX C 40 1555 1555 1.33 LINK C CSX C 40 N PHE C 41 1555 1555 1.33 CRYST1 40.167 83.222 150.886 90.00 90.00 90.00 P 2 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024896 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012016 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006628 0.00000 MASTER 372 0 2 18 23 0 0 6 0 0 0 46 END